LIBREDE
Librede Inc. is a company that has a mission to improve the quality of life through innovated sustainable technologies. Librede focuses on the creation of platform technologies that enable the creation of new therapeutics; they use biology to build devices and manufacture molecules. They have developed the world’s first biosynthetic production platform that is targeting the endocannabinoid system.
LIBREDE
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2009-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.librede.com
Total Employee:
1+
Status:
Closed
Contact:
1 (818) 835-5432
Total Funding:
1.64 M USD
Technology used in webpage:
Google Apps For Business Hover OpenSRS
Similar Organizations
Escend Pharmaceuticals
Escend Pharmaceuticals offers cancer therapeutics services.
Velocity Pharmaceutical Development
Velocity Pharmaceutical Development
Current Advisors List
Current Employees Featured
Founder
Investors List
National Center for Complementary and Integrative Health (NCCIH)
National Center for Complementary and Integrative Health (NCCIH) investment in Grant - Librede
National Science Foundation
National Science Foundation investment in Grant - Librede
Official Site Inspections
http://www.librede.com
- Host name: 159.89.244.183
- IP address: 159.89.244.183
- Location: Clifton United States
- Latitude: 40.8364
- Longitude: -74.1403
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07014
More informations about "Librede"
Librede - Crunchbase Company Profile & Funding
Librede Inc. is a company that has a mission to improve the quality of life through innovated sustainable technologies. Librede focuses on the creation of platform technologies that enable …See details»
Librede Company Profile - Office Locations, Competitors ... - Craft
See insights on Librede including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Librede Company Profile 2024: Valuation, Investors, Acquisition
Information on acquisition, funding, investors, and executives for Librede. Use the PitchBook Platform to explore the full profile.See details»
Librede | San Diego, CA, US Startup - Gust
Dec 1, 2013 · Librede, Inc. is a biotechnology company that has developed a new way of producing natural cannabinoids via fermentation - like making beer. Librede's proprietary yeast …See details»
LIBREDE, INC. - VentureRadar
Website: http://www.librede.com. Librede has developed a yeast based cannabinoid production and drug discovery platform to create chemical compounds that target the endocannabinoid …See details»
Lygos Acquires Librede to Accelerate Cannabinoid ... - SynBioBeta
BERKELEY, Calif.-- (BUSINESS WIRE)-- Lygos, Inc., a full-stack provider of sustainable specialty chemicals that deliver high-value performance without environmental toxicity, today …See details»
Lygos Acquires Librede to Accelerate Cannabinoid Production for ...
Jan 15, 2020 · Lygos acquires Librede, Inc., an emerging synthetic biology company focused on cannabinoid products for the consumer market.See details»
Lygos acquires Librede - 2020-01-15 - Crunchbase
Jan 15, 2020 · Librede High Quality Pharmaceuticals from Yeast. Acquiring Organization: Lygos Lygos provides biotechnology solutions for today’s renewable chemical challenges.See details»
Lygos Acquires Librede to Accelerate Cannabinoid Production for ...
Jan 15, 2020 · Lygos, Inc., a full-stack provider of sustainable specialty chemicals that deliver high-value performance without environmental toxicity, today announced the acquisition of …See details»
Librede - Crunchbase
High Quality Pharmaceuticals from Yeast.See details»
Librede - Graduated Companies - University of California, Los …
Librede’s patented yeast-based cannabinoid production platform can provide therapeutic cannabinoids to diverse markets in an economically and environmentally sustainable way. …See details»
Librede Inc. Awarded Highly Competitive Phase II SBIR Grant from …
Feb 13, 2018 · Librede receives Phase II SBIR from the NIH to optimize their yeast based cannabinoid production platform.See details»
Librede Wins $1.49 Million Government Grant to Develop Yeast …
Feb 13, 2018 · CARLSBAD, Calif.– (BUSINESS WIRE)– Librede, an early stage biotechnology company, has been awarded a $1,490,000 Phase II Small Business Innovative Research …See details»
Jason Poulos - Chief Executive Officer and Co-Founder @ Librede ...
As CEO of Librede, Dr. Poulos has managed multiple million dollar biotechnology projects and is responsible for the commercialization of Librede’s cannabinoid production and drug …See details»
Librede Inc. Awarded Highly Competitive Phase II SBIR Grant
Feb 13, 2018 · Librede has been awarded a $1,490,000 Phase II Small Business Innovative Research Grant (SBIR) from the National Center for Complementary and Integrative Health …See details»
Librede Inc. Receives Patent for Tetrahydrocannabinolic acid …
Apr 15, 2019 · SAN DIEGO-- ( BUSINESS WIRE )--Librede, a synthetic biology company based in Southern California, has been granted a new patent to produce tetrahydrocannabinolic acid …See details»
Librede - Contacts, Employees, Board Members, Advisors & Alumni
Librede has 3 current employee profiles, including Chief Executive Officer and Co-Founder Jason Poulos. Librede has 1 board member or advisor, Tarek Tabsh. High Quality Pharmaceuticals …See details»
Librede Inc. Receives Patent for Cannabidiolic Acid (CBDA) …
Jul 24, 2018 · Librede is a synthetic biology company that uses biologically-based approaches to produce high value natural products with a focus on cannabinoids. Librede’s patented yeast …See details»
LibReDE - Chair of Computer Science II - Software Engineering
Dec 8, 2023 · LibReDE is a library of ready-to-use implementations of state-of-the-art approaches to resource demand estimation that can be used for online and offline analysis. It is the first …See details»
Librede Receives Phase I SBIR to Develop Yeast-Based …
Mar 22, 2016 · SAN DIEGO-- ( BUSINESS WIRE )-- Librede, a biotechnology company specializing in yeast-based cannabinoid production, announced that it has received a Small …See details»